Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy.
Ruwaard J, VAN DER Vlugt ER, Wolbink G. Ruwaard J, et al. J Rheumatol. 2019 Jan;46(1):117-118. doi: 10.3899/jrheum.180566. Epub 2018 Oct 15. J Rheumatol. 2019. PMID: 30323005 No abstract available.
Development of antibodies against humanized antitumor necrosis factor and loss of efficacy in a black spider monkey with inflammatory bowel disease.
Eekman DA, Hoyer MJ, van Vugt RM, Wolbink GJ, Mulder CJ, Dijkmans BA. Eekman DA, et al. J Clin Rheumatol. 2009 Feb;15(1):39. doi: 10.1097/RHU.0b013e318195b211. J Clin Rheumatol. 2009. PMID: 19125133 No abstract available.
Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters.
de Jong TD, Blits M, de Ridder S, Vosslamber S, Wolbink G, Nurmohamed MT, Verweij CL. de Jong TD, et al. Arthritis Res Ther. 2016 Dec 12;18(1):290. doi: 10.1186/s13075-016-1191-y. Arthritis Res Ther. 2016. PMID: 27955694 Free PMC article.
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Plasencia C, Wolbink G, Krieckaert CL, Kneepkens EL, Turk S, Jurado T, Martínez-Feito A, Navarro-Compán V, Bonilla G, Villalba A, Peiteado D, Nuño L, Martín-Mola E, Nurmohamed MT, van der Kleij D, Rispens T, Pascual-Salcedo D, Balsa A. Plasencia C, et al. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):655-62. Epub 2016 May 19. Clin Exp Rheumatol. 2016. PMID: 27214767 Clinical Trial.
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.
Plasencia C, Kneepkens EL, Wolbink G, Krieckaert CL, Turk S, Navarro-Compán V, L'Ami M, Nurmohamed MT, van der Horst-Bruinsma I, Jurado T, Diego C, Bonilla G, Villalba A, Peiteado D, Nuño L, van der Kleij D, Rispens T, Martín-Mola E, Balsa A, Pascual-Salcedo D. Plasencia C, et al. J Rheumatol. 2015 Sep;42(9):1638-46. doi: 10.3899/jrheum.141128. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178279
Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation.
van de Stadt LA, de Vrieze H, Derksen NI, Brouwer M, Wouters D, van Schaardenburg D, Wolbink G, Rispens T. van de Stadt LA, et al. Arthritis Rheumatol. 2014 May;66(5):1133-40. doi: 10.1002/art.38335. Arthritis Rheumatol. 2014. PMID: 24782178
Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF. Krieckaert CL, et al. Rheumatology (Oxford). 2013 Mar;52(3):547-53. doi: 10.1093/rheumatology/kes320. Epub 2012 Dec 5. Rheumatology (Oxford). 2013. PMID: 23221326
The acute-phase response is not predictive for the development of arthritis in seropositive arthralgia - a prospective cohort study.
Limper M, van de Stadt L, Bos W, de Kruif M, Spek A, Wolbink G, van Schaardenburg D, van Gorp E. Limper M, et al. J Rheumatol. 2012 Oct;39(10):1914-7. doi: 10.3899/jrheum.120586. Epub 2012 Aug 1. J Rheumatol. 2012. PMID: 22859350
Immunogenicity of biological therapeutics: from assay to patient.
Krieckaert C, Rispens T, Wolbink G. Krieckaert C, et al. Curr Opin Rheumatol. 2012 May;24(3):306-11. doi: 10.1097/BOR.0b013e3283521c4e. Curr Opin Rheumatol. 2012. PMID: 22388644 Review.
IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, Hamann D, Dijkmans BA, Lems WF. Vis M, et al. J Rheumatol. 2008 Mar;35(3):425-8. J Rheumatol. 2008. PMID: 18322974
173 results
Jump to page
Feedback